Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 6/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2419579 | 1.00 | ACE (0.51) | ACEPTPN1SLC1A2IDO1CA2 | |
| SCHEMBL6411060 | 1.00 | ACE (0.51) | ACEPTPN1SLC1A2IDO1CA2 | |
| SCHEMBL8787239 | 0.91 | SLC1A2 (0.49) | ACEPTPN1SLC1A2CA2CA1 | |
| SCHEMBL14671279 | 0.88 | ACE (0.55) | ACEPTPN1CA2CA1KMT2A | |
| SCHEMBL4954825 | 0.88 | FNTA (0.54) | ACEPTPN1CA2CA1MEN1 | |
| SCHEMBL12020054 | 0.87 | CYP26A1 (0.48) | MEN1KMT2ATDP1LMNAHSD17B10 | |
| SCHEMBL12019153 | 0.86 | ALDH1A1 (0.51) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| SCHEMBL2806082 | 0.85 | ALDH1A1 (0.50) | ACEPTPN1SLC1A2IDO1CA2 | |
| SCHEMBL10805856 | 0.85 | PTPN1 (0.50) | ACEPTPN1SLC1A2IDO1CA2 | |
| SCHEMBL2806085 | 0.85 | ALDH1A1 (0.50) | ACEPTPN1SLC1A2IDO1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117137860-A | Preparation and application of isoniazid and amino acid-based in-situ hydrogel material | 赣南师范大学 | 2023-12-01 | — | — | CN | claimed |
| CN-110527662-B | Injection type cystine micromolecule gel material and application thereof | 赣南师范大学 | 2022-11-04 | — | — | CN | claimed |
| US-9410000-B2 | Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels | UNIVERSITA' DEGLI STUDI DI PALERMO (IT) | 2016-08-09 | — | — | US | claimed |
| US-9180195-B2 | Controlled release gels | NANO FIBER MATRICES B.V. (NL) | 2015-11-10 | — | — | US | claimed |
| US-20150183891-A1 | METHOD TO PRODUCE HYALURONIC ACID FUNCTIONALIZED DERIVATIVES AND FORMATION OF HYDROGELS | UNIVERSITA' DEGLI STUDI DI PALERMO (IT) | 2015-07-02 | — | — | US | claimed |
| US-8858999-B2 | Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels thereof | UNIVERSITA' DEGLI STUDI DI PALERMO (IT) | 2014-10-14 | — | — | US | claimed |
| EP-2370474-B1 | METHOD TO PRODUCE HYALURONIC ACID FUNCTIONALIZED DERIVATIVES AND FORMATION OF HYDROGELS THEREOF | UNIV PALERMO (IT) | 2012-10-24 | — | — | EP | claimed |
| US-20110236486-A1 | METHOD TO PRODUCE HYALURONIC ACID FUNCTIONALIZED DERIVATIVES AND FORMATION OF HYDROGELS THEREOF | UNIVERSITA' DEGLI STUDI DI PALERMO (IT) | 2011-09-29 | — | — | US | claimed |
| EP-1631261-B1 | PRODUCTION OF SMALL PARTICLES | APPLIED NANOSYSTEMS BV (NL) | 2009-07-15 | — | — | EP | claimed |
| US-20090169498-A1 | Controlled Release Gels | NANO FIBER MATRICES B.V. (NL) | 2009-07-02 | — | — | US | claimed |
| EP-1968638-A1 | CONTROLLED RELEASE GELS | Applied NanoSystems B.V. (NL) | 2008-09-17 | — | — | EP | claimed |
| WO-2007073180-A1 | CONTROLLED RELEASE GELS | APPLIED NANOSYSTEMS B.V. (NL) | 2007-06-28 | — | — | WO | claimed |
| EP-1800694-A1 | Controlled release gels | Applied NanoSystems B.V. (NL) | 2007-06-27 | — | — | EP | claimed |
| US-12584080-B2 | Gel-like shaped body for fragrancing textiles during the washing process | HENKEL AG & CO. KGAA (DE) | 2026-03-24 | — | — | US | disclosed |
| EP-4508181-B1 | METHOD FOR MANUFACTURING A DETERGENT PORTION UNIT | HENKEL AG & CO KGAA (DE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4508180-B1 | METHOD FOR MANUFACTURING A DETERGENT PORTION UNIT | HENKEL AG & CO KGAA (DE) | 2026-01-14 | — | — | EP | disclosed |
| US-5204248-A | Enzymatic reduction of corresponding oxo derivative; intermediate for diltiazem | TANABE SEIYAKU CO., LTD. (JP) | 1993-04-20 | — | — | US | disclosed |
| US-5081240-A | PROCESS FOR THE PREPARATION OF BENZOTHIAZEPIN-ONE DERIVATIVES | SANOFI (FR) | 1992-01-14 | — | — | US | disclosed |
| EP-0447938-A1 | Process for preparing 2-halogeno-3-hydroxy-3-phenyl-propionic acid ester compounds | TANABE SEIYAKU CO., LTD. (JP) | 1991-09-25 | — | — | EP | disclosed |
| EP-0409712-A1 | Process for the preparation of a stereoisomer of glycidyl esters, intermediates and process for the preparation of benzothiazepinone derivatives | ELF SANOFI (FR) | 1991-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584080-B2 | Gel-like shaped body for fragrancing textiles during the washing process | ADH1C, AKR1C3, AKR1C4 | ACE 3137/4885PTPN1 2294/4885SLC1A2 4753/4885 |
| US-20090169498-A1 | Controlled Release Gels | PGA5, SUCLG1, CDC37 | ACE 3304/4885PTPN1 2257/4885SLC1A2 4675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.